Live: Arista Networks Is Reporting Q1 Earnings. Can $ANET Continue Its 32% YTD Rally?

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Apr 21, 2016 at 10:05 AM EDT

Why TransEnterix Shares Are in Free Fall

TransEnterix has announced that the FDA notified it that its SurgiBot System does not meet the criteria for substantial equivalence…

Chris Lange | Apr 20, 2016 at 11:15 AM EDT

American Renal Associates Prepares to Enter the Market With Updated IPO Filing

American Renal Associates expects to price more than 7 million shares in the range of $20 to $23 per share…

Jon C. Ogg | Apr 20, 2016 at 11:05 AM EDT

Can BioMarin Make Treating Hemophilia More Affordable?

BioMarin Pharmaceutical is ready to break above the $1 billion revenue barrier in 2016, a feat that marks a major…

Chris Lange | Apr 20, 2016 at 10:05 AM EDT

Spectrum Pharma Jumps on FDA Orphan Designation

Spectrum Pharmaceuticals announced that the FDA has granted seven years of Orphan Drug exclusivity for Evomela.

Chris Lange | Apr 20, 2016 at 9:55 AM EDT

Cara Therapeutics Rises on FDA Judgment

Cara Therapeutics saw its shares jump early on Wednesday after it announced that it has received notice from the FDA…

Chris Lange | Apr 19, 2016 at 12:25 PM EDT

Gemphire Therapeutics Gears Up for IPO

Gemphire Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).

Paul Ausick | Apr 19, 2016 at 7:55 AM EDT

Johnson & Johnson Raises Forecast on Weaker Dollar

Johnson & Johnson reported better-than-expected first-quarter 2016 results before markets opened Tuesday morning.

Paul Ausick | Apr 19, 2016 at 7:35 AM EDT

UnitedHealth Raises Outlook Following Strong Q1 Earnings

UnitedHealth Group reported better-than-expected first-quarter 2016 results before markets opened Tuesday morning.

Douglas A. McIntyre | Apr 19, 2016 at 6:56 AM EDT

Theranos Valuation May Drop to Zero

According to The Wall Street Journal, the reasons Theranos may lose all of its value have been bolstered by an…

Lee Jackson | Apr 18, 2016 at 10:20 AM EDT

Biotech and Pharmaceuticals Highlight Jefferies Top Growth Stock Buys

New research from Jefferies highlights this week's top growth stock picks, and there is a clear bias for some top…

Chris Lange | Apr 17, 2016 at 10:25 AM EDT

Are Analysts Realistic on Clovis Oncology Now?

Shares of Clovis Oncology dropped after the FDA Oncologic Drugs Advisory Committee voted against its lung cancer drug.

Chris Lange | Apr 15, 2016 at 12:25 PM EDT

Is PTC Therapeutics on the Road to Recovery?

PTC Therapeutics saw its shares jump late Friday morning on positive news on its nonsense mutation Duchenne muscular dystrophy treatment.

Paul Ausick | Apr 14, 2016 at 11:45 AM EDT

Valeant Debt Downgraded at S&P

Valeant Pharmaceuticals got another dose of bad news Thursday morning. Standard & Poor's Ratings Services dropped the Canadian drugmaker's corporate…

Chris Lange | Apr 12, 2016 at 9:55 AM EDT

Short Sellers Run for Cover From Major Biotechs

The March 31 short interest data have been compared with the previous report, and short interest decreased across the board…

Chris Lange | Apr 12, 2016 at 9:50 AM EDT

Short Sellers Become More Selective in Major Pharma

The March 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

1 … 214 215 216 217 218 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why TransEnterix Shares Are in Free Fall

American Renal Associates Prepares to Enter the Market With Updated IPO Filing

Can BioMarin Make Treating Hemophilia More Affordable?

Spectrum Pharma Jumps on FDA Orphan Designation

Cara Therapeutics Rises on FDA Judgment

Gemphire Therapeutics Gears Up for IPO

Johnson & Johnson Raises Forecast on Weaker Dollar

UnitedHealth Raises Outlook Following Strong Q1 Earnings

Theranos Valuation May Drop to Zero

Biotech and Pharmaceuticals Highlight Jefferies Top Growth Stock Buys

Are Analysts Realistic on Clovis Oncology Now?

Is PTC Therapeutics on the Road to Recovery?

Valeant Debt Downgraded at S&P

Short Sellers Run for Cover From Major Biotechs

Short Sellers Become More Selective in Major Pharma

Live: Arista Networks Is Reporting Q1 Earnings. Can $ANET Continue Its 32% YTD Rally?

Live: AMD Reports Q1 Earnings Tonight. Will the Stock Continue Its 255% 1-Year Explosion?

Live: Lumentum Q3 Earnings Tonight. Can the 15x Surge Continue?

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Jim Cramer Isn’t a Fan of Microsoft After Rough Quarter. Is He Right to Be Skeptical?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

Health and Healthcare Articles

All Health and Healthcare Articles

Why TransEnterix Shares Are in Free Fall

American Renal Associates Prepares to Enter the Market With Updated IPO Filing

Can BioMarin Make Treating Hemophilia More Affordable?

Spectrum Pharma Jumps on FDA Orphan Designation

Cara Therapeutics Rises on FDA Judgment

Gemphire Therapeutics Gears Up for IPO

Johnson & Johnson Raises Forecast on Weaker Dollar

UnitedHealth Raises Outlook Following Strong Q1 Earnings

Theranos Valuation May Drop to Zero

Biotech and Pharmaceuticals Highlight Jefferies Top Growth Stock Buys

Are Analysts Realistic on Clovis Oncology Now?

Is PTC Therapeutics on the Road to Recovery?

Valeant Debt Downgraded at S&P

Short Sellers Run for Cover From Major Biotechs

Short Sellers Become More Selective in Major Pharma

Live: Arista Networks Is Reporting Q1 Earnings. Can $ANET Continue Its 32% YTD Rally?

Live: AMD Reports Q1 Earnings Tonight. Will the Stock Continue Its 255% 1-Year Explosion?

Live: Lumentum Q3 Earnings Tonight. Can the 15x Surge Continue?

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Jim Cramer Isn’t a Fan of Microsoft After Rough Quarter. Is He Right to Be Skeptical?

Featured Reads

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income